ONJ With Bone-Modifying Agents in Breast Cancer Patients ONJ With Bone-Modifying Agents in Breast Cancer Patients

Osteonecrosis of the jaw was reported in metastatic breast cancer patients treated with bone-modifying agents; the incidence was higher with denosumab compared with bisphosphonates.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news